Cita APA

Martínez, C., Haro, M. E. d., Romero, S., Gutierrez, A., Domingo Domènech, E., González Rodríguez, A. P., . . . Garcia Sanz, R. (2022). Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma.

Citación estilo Chicago

Martínez, Carmen, et al. Impact of Pre- And/or Post-autologous Stem Cell Transplantation Exposure to Brentuximab Vedotin On Survival Outcomes in Patients With High-risk Hodgkin Lymphoma. 2022.

Cita MLA

Martínez, Carmen, et al. Impact of Pre- And/or Post-autologous Stem Cell Transplantation Exposure to Brentuximab Vedotin On Survival Outcomes in Patients With High-risk Hodgkin Lymphoma. 2022.